Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fruquintinib with Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT05575635Phase 2Unknown
- Sponsor
- Henan Provincial People's Hospital
- Start
- Nov 2022
- Primary completion
- May 2024
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
01
Overview
A Phase 2 trial of fruquintinib in rectal cancer, sponsored by Henan Provincial People's Hospital. Status: unknown.
02
Drugs
fruquintinib
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT05575635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05575635.